John Riefler, MD

Study measures the differing judgment levels between clinical investigators and drug safety experts.

Drug safety surveillance, a core focus of clinical trials, can be influenced by subjective judgement, as this analysis of differing expert assessments of adverse drug reactions-and the reasons why-shows.